Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Growth (Status and Outlook) 2026-2032

March 2026 | 76 pages | ID: G4A2C0754B9CEN
LP Information

Abstracts

The global PMO (Phosphorodiamidate Morpholino Oligomers) Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

The advantage of PMO drugs is that they can regulate target genes at two levels: splicing conversion and translation level blocking. Currently, they are mostly used to treat Duchenne muscular dystrophy.

United States market for PMO (Phosphorodiamidate Morpholino Oligomers) Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for PMO (Phosphorodiamidate Morpholino Oligomers) Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for PMO (Phosphorodiamidate Morpholino Oligomers) Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key PMO (Phosphorodiamidate Morpholino Oligomers) Drug players cover Sarepta Therapeutics, Inc, NS Pharma, Inc., Nippon Shinyaku, Dyne, Avidity Biosciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the “PMO (Phosphorodiamidate Morpholino Oligomers) Drug Industry Forecast” looks at past sales and reviews total world PMO (Phosphorodiamidate Morpholino Oligomers) Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected PMO (Phosphorodiamidate Morpholino Oligomers) Drug sales for 2026 through 2032. With PMO (Phosphorodiamidate Morpholino Oligomers) Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PMO (Phosphorodiamidate Morpholino Oligomers) Drug industry.

This Insight Report provides a comprehensive analysis of the global PMO (Phosphorodiamidate Morpholino Oligomers) Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on PMO (Phosphorodiamidate Morpholino Oligomers) Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global PMO (Phosphorodiamidate Morpholino Oligomers) Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PMO (Phosphorodiamidate Morpholino Oligomers) Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PMO (Phosphorodiamidate Morpholino Oligomers) Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of PMO (Phosphorodiamidate Morpholino Oligomers) Drug market by product type, application, key players and key regions and countries.

Segmentation by Type:

• DMD exon 51 Based
• DMD exon 53 Based
• DMD exon 45 Based
• Other

Segmentation by Application:

• Hospital
• Clinic

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Sarepta Therapeutics, Inc
• NS Pharma, Inc.
• Nippon Shinyaku
• Dyne
• Avidity Biosciences

The report requires updating with new data and is sent in 48 hours after order is placed.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size (2021-2032)
  2.1.2 PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for PMO (Phosphorodiamidate Morpholino Oligomers) Drug by Country/Region (2021, 2025 & 2032)
2.2 PMO (Phosphorodiamidate Morpholino Oligomers) Drug Segment by Type
  2.2.1 DMD exon 51 Based
  2.2.2 DMD exon 53 Based
  2.2.3 DMD exon 45 Based
  2.2.4 Other
  2.2.5 PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Type
    2.2.5.1 PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.5.2 Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Market Share by Type (2021-2026)
2.3 PMO (Phosphorodiamidate Morpholino Oligomers) Drug Segment by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Application
    2.3.3.1 PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.3.2 Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Market Share by Application (2021-2026)

3 PMO (PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS) DRUG MARKET SIZE BY PLAYER

3.1 PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Market Share by Player
  3.1.1 Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue by Player (2021-2026)
  3.1.2 Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue Market Share by Player (2021-2026)
3.2 Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PMO (PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS) DRUG BY REGION

4.1 PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Region (2021-2026)
4.2 Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth (2021-2026)
4.4 APAC PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth (2021-2026)
4.5 Europe PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth (2021-2026)
4.6 Middle East & Africa PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Country (2021-2026)
5.2 Americas PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Type (2021-2026)
5.3 Americas PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Region (2021-2026)
6.2 APAC PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Type (2021-2026)
6.3 APAC PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Country (2021-2026)
7.2 Europe PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Type (2021-2026)
7.3 Europe PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa PMO (Phosphorodiamidate Morpholino Oligomers) Drug by Region (2021-2026)
8.2 Middle East & Africa PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Type (2021-2026)
8.3 Middle East & Africa PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PMO (PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS) DRUG MARKET FORECAST

10.1 Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast by Region (2027-2032)
  10.1.1 Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast by Region (2027-2032)
  10.1.2 Americas PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast
  10.1.3 APAC PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast
  10.1.4 Europe PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast
  10.1.5 Middle East & Africa PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast
10.2 Americas PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast by Country (2027-2032)
  10.2.1 United States Market PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast
  10.2.2 Canada Market PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast
  10.2.3 Mexico Market PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast
  10.2.4 Brazil Market PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast
10.3 APAC PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast by Region (2027-2032)
  10.3.1 China PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Forecast
  10.3.2 Japan Market PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast
  10.3.3 Korea Market PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast
  10.3.4 Southeast Asia Market PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast
  10.3.5 India Market PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast
  10.3.6 Australia Market PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast
10.4 Europe PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast by Country (2027-2032)
  10.4.1 Germany Market PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast
  10.4.2 France Market PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast
  10.4.3 UK Market PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast
  10.4.4 Italy Market PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast
  10.4.5 Russia Market PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast
10.5 Middle East & Africa PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast by Region (2027-2032)
  10.5.1 Egypt Market PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast
  10.5.2 South Africa Market PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast
  10.5.3 Israel Market PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast
  10.5.4 Turkey Market PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast
10.6 Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast by Type (2027-2032)
10.7 Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecast

11 KEY PLAYERS ANALYSIS

11.1 Sarepta Therapeutics, Inc
  11.1.1 Sarepta Therapeutics, Inc Company Information
  11.1.2 Sarepta Therapeutics, Inc PMO (Phosphorodiamidate Morpholino Oligomers) Drug Product Offered
  11.1.3 Sarepta Therapeutics, Inc PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Sarepta Therapeutics, Inc Main Business Overview
  11.1.5 Sarepta Therapeutics, Inc Latest Developments
11.2 NS Pharma, Inc.
  11.2.1 NS Pharma, Inc. Company Information
  11.2.2 NS Pharma, Inc. PMO (Phosphorodiamidate Morpholino Oligomers) Drug Product Offered
  11.2.3 NS Pharma, Inc. PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 NS Pharma, Inc. Main Business Overview
  11.2.5 NS Pharma, Inc. Latest Developments
11.3 Nippon Shinyaku
  11.3.1 Nippon Shinyaku Company Information
  11.3.2 Nippon Shinyaku PMO (Phosphorodiamidate Morpholino Oligomers) Drug Product Offered
  11.3.3 Nippon Shinyaku PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Nippon Shinyaku Main Business Overview
  11.3.5 Nippon Shinyaku Latest Developments
11.4 Dyne
  11.4.1 Dyne Company Information
  11.4.2 Dyne PMO (Phosphorodiamidate Morpholino Oligomers) Drug Product Offered
  11.4.3 Dyne PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Dyne Main Business Overview
  11.4.5 Dyne Latest Developments
11.5 Avidity Biosciences
  11.5.1 Avidity Biosciences Company Information
  11.5.2 Avidity Biosciences PMO (Phosphorodiamidate Morpholino Oligomers) Drug Product Offered
  11.5.3 Avidity Biosciences PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Avidity Biosciences Main Business Overview
  11.5.5 Avidity Biosciences Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. PMO (Phosphorodiamidate Morpholino Oligomers) Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of DMD exon 51 Based
Table 4. Major Players of DMD exon 53 Based
Table 5. Major Players of DMD exon 45 Based
Table 6. Major Players of Other
Table 7. PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Type (2021-2026) & ($ millions)
Table 9. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Market Share by Type (2021-2026)
Table 10. PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Application (2021-2026) & ($ millions)
Table 12. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Market Share by Application (2021-2026)
Table 13. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue by Player (2021-2026) & ($ millions)
Table 14. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue Market Share by Player (2021-2026)
Table 15. PMO (Phosphorodiamidate Morpholino Oligomers) Drug Key Players Head office and Products Offered
Table 16. PMO (Phosphorodiamidate Morpholino Oligomers) Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Region (2021-2026) & ($ millions)
Table 20. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Market Share by Region (2021-2026)
Table 21. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Market Share by Country (2021-2026)
Table 25. Americas PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Market Share by Type (2021-2026)
Table 27. Americas PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Market Share by Application (2021-2026)
Table 29. APAC PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Market Share by Region (2021-2026)
Table 31. APAC PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Market Share by Country (2021-2026)
Table 35. Europe PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of PMO (Phosphorodiamidate Morpholino Oligomers) Drug
Table 41. Key Market Challenges & Risks of PMO (Phosphorodiamidate Morpholino Oligomers) Drug
Table 42. Key Industry Trends of PMO (Phosphorodiamidate Morpholino Oligomers) Drug
Table 43. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Sarepta Therapeutics, Inc Details, Company Type, PMO (Phosphorodiamidate Morpholino Oligomers) Drug Area Served and Its Competitors
Table 48. Sarepta Therapeutics, Inc PMO (Phosphorodiamidate Morpholino Oligomers) Drug Product Offered
Table 49. Sarepta Therapeutics, Inc PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Sarepta Therapeutics, Inc Main Business
Table 51. Sarepta Therapeutics, Inc Latest Developments
Table 52. NS Pharma, Inc. Details, Company Type, PMO (Phosphorodiamidate Morpholino Oligomers) Drug Area Served and Its Competitors
Table 53. NS Pharma, Inc. PMO (Phosphorodiamidate Morpholino Oligomers) Drug Product Offered
Table 54. NS Pharma, Inc. PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. NS Pharma, Inc. Main Business
Table 56. NS Pharma, Inc. Latest Developments
Table 57. Nippon Shinyaku Details, Company Type, PMO (Phosphorodiamidate Morpholino Oligomers) Drug Area Served and Its Competitors
Table 58. Nippon Shinyaku PMO (Phosphorodiamidate Morpholino Oligomers) Drug Product Offered
Table 59. Nippon Shinyaku PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Nippon Shinyaku Main Business
Table 61. Nippon Shinyaku Latest Developments
Table 62. Dyne Details, Company Type, PMO (Phosphorodiamidate Morpholino Oligomers) Drug Area Served and Its Competitors
Table 63. Dyne PMO (Phosphorodiamidate Morpholino Oligomers) Drug Product Offered
Table 64. Dyne PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Dyne Main Business
Table 66. Dyne Latest Developments
Table 67. Avidity Biosciences Details, Company Type, PMO (Phosphorodiamidate Morpholino Oligomers) Drug Area Served and Its Competitors
Table 68. Avidity Biosciences PMO (Phosphorodiamidate Morpholino Oligomers) Drug Product Offered
Table 69. Avidity Biosciences PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Avidity Biosciences Main Business
Table 71. Avidity Biosciences Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. PMO (Phosphorodiamidate Morpholino Oligomers) Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. PMO (Phosphorodiamidate Morpholino Oligomers) Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. PMO (Phosphorodiamidate Morpholino Oligomers) Drug Sales Market Share by Country/Region (2025)
Figure 8. PMO (Phosphorodiamidate Morpholino Oligomers) Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Market Share by Type in 2025
Figure 10. PMO (Phosphorodiamidate Morpholino Oligomers) Drug in Hospital
Figure 11. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market: Hospital (2021-2026) & ($ millions)
Figure 12. PMO (Phosphorodiamidate Morpholino Oligomers) Drug in Clinic
Figure 13. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market: Clinic (2021-2026) & ($ millions)
Figure 14. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Market Share by Application in 2025
Figure 15. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue Market Share by Player in 2025
Figure 16. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Market Share by Region (2021-2026)
Figure 17. Americas PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2021-2026 ($ millions)
Figure 18. APAC PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2021-2026 ($ millions)
Figure 19. Europe PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2021-2026 ($ millions)
Figure 21. Americas PMO (Phosphorodiamidate Morpholino Oligomers) Drug Value Market Share by Country in 2025
Figure 22. United States PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Market Share by Region in 2025
Figure 27. APAC PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Market Share by Type (2021-2026)
Figure 28. APAC PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Market Share by Application (2021-2026)
Figure 29. China PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth 2021-2026 ($ millions)
Figure 33. India PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Market Share by Country in 2025
Figure 36. Europe PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Market Share by Type (2021-2026)
Figure 37. Europe PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Market Share by Application (2021-2026)
Figure 38. Germany PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth 2021-2026 ($ millions)
Figure 39. France PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth 2021-2026 ($ millions)
Figure 40. UK PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Market Share by Application (2021-2026)
Figure 46. Egypt PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2027-2032 ($ millions)
Figure 52. APAC PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2027-2032 ($ millions)
Figure 53. Europe PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2027-2032 ($ millions)
Figure 55. United States PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2027-2032 ($ millions)
Figure 56. Canada PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2027-2032 ($ millions)
Figure 57. Mexico PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2027-2032 ($ millions)
Figure 58. Brazil PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2027-2032 ($ millions)
Figure 59. China PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2027-2032 ($ millions)
Figure 60. Japan PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2027-2032 ($ millions)
Figure 61. Korea PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2027-2032 ($ millions)
Figure 63. India PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2027-2032 ($ millions)
Figure 64. Australia PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2027-2032 ($ millions)
Figure 65. Germany PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2027-2032 ($ millions)
Figure 66. France PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2027-2032 ($ millions)
Figure 67. UK PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2027-2032 ($ millions)
Figure 68. Italy PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2027-2032 ($ millions)
Figure 69. Russia PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2027-2032 ($ millions)
Figure 70. Egypt PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2027-2032 ($ millions)
Figure 71. South Africa PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2027-2032 ($ millions)
Figure 72. Israel PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2027-2032 ($ millions)
Figure 73. Turkey PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2027-2032 ($ millions)
Figure 74. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size 2027-2032 ($ millions)